Expertise in
2
conditions

Vaidotas Urbonas

Vilnius, VL, LT 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Vilnius, VL, LT 

Overview

Vaidotas Urbonas practices practicing medicine in Vilnius, Lithuania.

Urbonas is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Helicobacter Pylori Infection, Eosinophilic Esophagitis, Esophagitis, Endoscopy, and Liver Transplant.

They are actively involved in clinical research, co-authoring 39 peer reviewed articles and participating in 2 clinical trials.

Locations

Vilnius, VL 03101, Lithuania

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Crohn's Disease Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Recruiting
Publish Date: May 05, 2026
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
A Randomized, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of Vedolizumab Intravenous as Maintenance Therapy in Pediatric Subjects With Moderately to Severely Active Ulcerative Colitis Who Achieved Clinical Response Following Open-Label Vedolizumab Intravenous Therapy
Enrollment Status: Completed
Publish Date: April 30, 2026
Intervention Type: Drug
Study Drug: Vedolizumab
Study Phase: Phase 3
View 1 Less Clinical Trial

39 Total Publications

Safety of Fecal Microbiota Transplantation in Children: A Single-Center Experience.
Safety of Fecal Microbiota Transplantation in Children: A Single-Center Experience.
Journal: Children (Basel, Switzerland)
Published: May 22, 2026

Frequently Asked Questions about Vaidotas Urbonas

Is Vaidotas Urbonas a top-rated expert for Helicobacter Pylori Infection?

MediFind is an objective health platform that identifies experts based on real-world data. Vaidotas Urbonas is classified as an Advanced expert for Helicobacter Pylori Infection, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vaidotas Urbonas participate in research or clinical trials?

Yes. Vaidotas Urbonas has published 39 articles and abstracts on conditions like Helicobacter Pylori Infection. You can view a list of Vaidotas Urbonas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Urbonas's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile